<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Therapy-related <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is a very rare complication of allogeneic bone marrow transplantation (BMT) </plain></SENT>
<SENT sid="1" pm="."><plain>A woman with T <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e>) received an allogeneic BMT from a donor with the beta-thalassaemic trait </plain></SENT>
<SENT sid="2" pm="."><plain>Five years after BMT, the red cell indices returned to <z:mpath ids='MPATH_458'>normal</z:mpath> after an initial conversion to <z:mp ids='MP_0002813'>microcytosis</z:mp>, implying autologous haematopoietic regeneration </plain></SENT>
<SENT sid="3" pm="."><plain>Seven years after BMT, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> developed and marrow examination confirmed t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, with a characteristic karyotype 46,XX,inv(3)(q21;q26), del(5)(q13),add(17)(p11) </plain></SENT>
<SENT sid="4" pm="."><plain>Retrospective molecular analysis of donor/recipient chimaerism showed gradual regeneration of recipient cells after BMT, culminating at the time of t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Our findings illustrate the unusual occurrence of t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> after allogeneic BMT </plain></SENT>
<SENT sid="6" pm="."><plain>Re-emergence of recipient haematopoesis may herald the development of a <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">haematological malignancy</z:e> different from the original neoplastic clone for which the BMT was performed </plain></SENT>
</text></document>